| Dr Justin Michael Fox, MD | |
|
2073 Klockner Rd, Hamilton, NJ 08690-3414 | |
| (609) 584-1212 | |
| (609) 584-0103 |
| Full Name | Dr Justin Michael Fox |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 20 Years |
| Location | 2073 Klockner Rd, Hamilton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629269600 | NPI | - | NPPES |
| 22-3052989 | Other | NJ | TAX ID# |
| 0267694 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hamilton Cardiology Associates Pa | 4284629932 | 19 |
News Archive
Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. But other considerations must also be taken into account, say researchers.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.
What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 1 days ago
| Entity Name | Hamilton Cardiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326026378 PECOS PAC ID: 4284629932 Enrollment ID: O20040420000887 |
News Archive
Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. But other considerations must also be taken into account, say researchers.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.
What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 1 days ago
| Entity Name | Princeton Healthcare Affiliated Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518194323 PECOS PAC ID: 2567598022 Enrollment ID: O20100413000141 |
News Archive
Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. But other considerations must also be taken into account, say researchers.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.
What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 1 days ago
| Entity Name | Princeton Healthcare Provider Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699141507 PECOS PAC ID: 3173824695 Enrollment ID: O20151228002256 |
News Archive
Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. But other considerations must also be taken into account, say researchers.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.
What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Michael Fox, MD 2073 Klockner Rd, Hamilton, NJ 08690-3414 Ph: (609) 584-1212 | Dr Justin Michael Fox, MD 2073 Klockner Rd, Hamilton, NJ 08690-3414 Ph: (609) 584-1212 |
News Archive
Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. But other considerations must also be taken into account, say researchers.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.
What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 1 days ago
Mrs. Ebele Edith Ufondu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 941 Whitehorse Avenue, Suite 14, Hamilton, NJ 08610 Phone: 609-581-4800 Fax: 609-581-9980 | |
Dr. Ali Raza, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Whitehorse Mercerville Rd, Suite 306, Hamilton, NJ 08619 Phone: 609-581-9000 | |
John Stabile, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Whitehorse Mercerville Rd Ste 218, Hamilton, NJ 08619 Phone: 609-689-5760 Fax: 609-689-5759 | |
Adam Lucas, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2073 Klockner Rd, Hamilton, NJ 08690 Phone: 609-584-1212 Fax: 609-584-0103 | |
Dr. Marcella M. Frank, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Whitehourse-mercerville Road, Suite 219, Hamilton, NJ 08619 Phone: 609-584-5150 Fax: 602-584-5144 | |
Dr. Neerja Misra, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2279 Highway 33 Ste 518, Hamilton, NJ 08690 Phone: 609-689-9001 Fax: 609-689-9002 | |
Dr. Akbar H Obaray, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2069 Klockner Rd, Hamilton, NJ 08690 Phone: 609-586-0031 Fax: 609-586-0708 |